mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.7 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
paclitaxel |
FIMM |
pan-cancer |
AAC |
0.061 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.7 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
0.071 |
0.7 |